Company profile: L7 Informatics
1.1 - Company Overview
Company description
- Provider of a unified platform (L7|ESP) that contextualizes data and orchestrates processes to eliminate business silos and streamline development and manufacturing of advanced therapeutics, diagnostics, and small molecule drugs. Solutions include data management and analytics for molecular diagnostics, companion diagnostics development integrating clinical, genomic, and patient data, and CDMO support for efficiency, quality, and compliance.
Products and services
- L7|ESP: Enterprise-grade unified platform that contextualizes complex data and orchestrates processes, managing and analyzing datasets for advanced therapeutics, diagnostics, and small-molecule drug development with streamlined data management, collaboration, and advanced analytics
- CDMO Support: Manufacturing-scale platform that delivers centralized critical functions from development through manufacturing, enhancing operational efficiency, quality assurance, and regulatory compliance for Contract Development and Manufacturing Organizations
- Companion Diagnostics Development: Data-integrative platform that architects integration of clinical, genomic, and patient data to support the development and implementation of companion diagnostics
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to L7 Informatics
Paige
HQ: United States
Website
- Description: Provider of software to advance the diagnosis, treatment, and biomarker discovery for cancer.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Paige company profile →
ConcertAI
HQ: United States
Website
- Description: Provider of AI-powered SaaS medical research tools and integrated real-world data solutions for oncology. Offerings include AI-enriched datasets for clinical and outcomes research, regulatory-grade external control arms, pragmatic trials, post-approval studies, virtual EMR-claims registries, and regulatory research with custom real-world data abstraction and scientific consultation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ConcertAI company profile →
Jumpcode Genomics
HQ: United States
Website
- Description: Provider of CRISPR-mediated rRNA and DNA depletion kits for sequencing workflows, improving sensitivity and performance. Solutions include single-cell RNA boost kits (CRISPRclean, DepleteX) to remove uninformative transcripts and undesired fragments; bulk RNA/DNA depletion for stranded RNA-Seq; mitochondrial DNA, nasopharyngeal RNA, and human DNA depletion to enhance genomic and microbial analyses.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Jumpcode Genomics company profile →
NoviSci
HQ: United States
Website
- Description: Provider of principled data science to improve the health and well-being of people.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NoviSci company profile →
SmartSeq
HQ: Italy
Website
- Description: Provider of the Amplicon Suite software and integrated NGS data analysis tools, enabling analysis, visualization, and exploration of data.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full SmartSeq company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for L7 Informatics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to L7 Informatics
2.2 - Growth funds investing in similar companies to L7 Informatics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for L7 Informatics
4.2 - Public trading comparable groups for L7 Informatics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →